Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by dusoft24x7on Aug 01, 2016 3:24pm
264 Views
Post# 25100689

Goldman Sach has $26 target

Goldman Sach has $26 targetGoldman Sach price target has being the biggest reason for stock to retrace from thirties to low twenties. Everything other story just piled up alongside.

GS is very corrupt and manipulator as they are short Canada ( short on Gold prices, Oil, Canadian Banks, others..).

Facts are in favour of CXRX - Q1 cash flow was strong, Q2 will be stronger and will improves further in last 2 quarters with Q4 as strongest quarter. This as best is manipulated bottom, it is bound to go back up to $33 to $37 range after Q2 results.
<< Previous
Bullboard Posts
Next >>